GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alseres Pharmaceuticals Inc (OTCPK:ALSE) » Definitions » Cyclically Adjusted PB Ratio

Alseres Pharmaceuticals (Alseres Pharmaceuticals) Cyclically Adjusted PB Ratio : (As of May. 22, 2024)


View and export this data going back to . Start your Free Trial

What is Alseres Pharmaceuticals Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Alseres Pharmaceuticals Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Alseres Pharmaceuticals's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alseres Pharmaceuticals Cyclically Adjusted PB Ratio Chart

Alseres Pharmaceuticals Annual Data
Trend Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Alseres Pharmaceuticals Quarterly Data
Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Alseres Pharmaceuticals's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, Alseres Pharmaceuticals's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alseres Pharmaceuticals's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Alseres Pharmaceuticals's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Alseres Pharmaceuticals's Cyclically Adjusted PB Ratio falls into.



Alseres Pharmaceuticals Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Alseres Pharmaceuticals's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2014 is calculated as:

For example, Alseres Pharmaceuticals's adjusted Book Value per Share data for the three months ended in Jun. 2014 was:

Adj_Book=Book Value per Share/CPI of Jun. 2014 (Change)*Current CPI (Jun. 2014)
=-1856.444/100.5595*100.5595
=-1,856.444

Current CPI (Jun. 2014) = 100.5595.

Alseres Pharmaceuticals Quarterly Data

Book Value per Share CPI Adj_Book
200409 -671.014 80.121 -842.189
200412 -2,125.362 80.290 -2,661.931
200503 2,071.154 81.555 2,553.779
200506 887.981 82.062 1,088.145
200509 3,354.242 83.876 4,021.433
200512 2,391.212 83.032 2,895.981
200603 1,372.424 84.298 1,637.175
200606 336.061 85.606 394.765
200609 -722.892 85.606 -849.168
200612 -4,991.566 85.142 -5,895.466
200703 -6,084.731 86.640 -7,062.282
200706 -3,526.329 87.906 -4,033.926
200709 -4,234.541 87.964 -4,840.871
200712 -5,414.010 88.616 -6,143.672
200803 -6,455.288 90.090 -7,205.491
200806 -7,831.971 92.320 -8,530.932
200809 -8,922.542 92.307 -9,720.252
200812 -8,679.610 88.697 -9,840.393
200903 -9,121.258 89.744 -10,220.484
200906 -9,683.731 91.003 -10,700.625
200909 -10,133.189 91.120 -11,182.977
200912 -9,297.260 91.111 -10,261.393
201003 -9,138.262 91.821 -10,007.962
201006 -9,451.017 91.962 -10,334.612
201009 -8,572.828 92.162 -9,353.986
201012 -8,822.015 92.474 -9,593.371
201103 -9,038.619 94.283 -9,640.317
201106 -6,974.204 95.235 -7,364.164
201109 -6,968.819 95.727 -7,320.627
201112 -4,992.170 95.213 -5,272.473
201203 -5,044.209 96.783 -5,241.041
201206 -5,095.269 96.819 -5,292.108
201209 -5,236.215 97.633 -5,393.162
201212 -4,359.054 96.871 -4,525.026
201303 -4,371.615 98.209 -4,476.225
201306 -4,449.103 98.518 -4,541.307
201309 -4,509.299 98.790 -4,590.068
201312 -1,738.825 98.326 -1,778.325
201403 -1,797.390 99.695 -1,812.985
201406 -1,856.444 100.560 -1,856.444

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Alseres Pharmaceuticals  (OTCPK:ALSE) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Alseres Pharmaceuticals Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Alseres Pharmaceuticals's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Alseres Pharmaceuticals (Alseres Pharmaceuticals) Business Description

Traded in Other Exchanges
N/A
Address
275 Grove Street, Suite 2-400, Auburndale, MA, USA, 02466
Alseres Pharmaceuticals Inc is a US-based biotechnology company. It is focused on the development of diagnostic and therapeutic products for disorders in the central nervous system. The company's lead product candidate is Altropane, a proprietary molecular imaging agent which is used to diagnose Parkinson's disease and dementia. Further, it is focused on entering into partnerships to ensure development and commercialization of its product. Geographically the firm carries out its business through the region of United States.
Executives
Mark Jerome Pykett officer: President and COO 223A MAIN ST, BOXFORD MA 021921
Robert Langer director 98 MONTVALE RD, NEWTON MA 02459
Peter G Savas director, officer: Chief Executive Officer 110 HARTWELL AVENUE, LEXINGTON MA 02173
John T Preston director C/O MOLTEN METAL TECHNOLOTY INC, 400-2 TOTTEN POND ROAD, WALTHAM MA 02154
Rice Kenneth L Jr officer: Exec VP of Fin & Admin & CFO C/O 85 MAIN STREET, HOPKINTON MA 01748
Joseph P Hernon officer: Chief Financial Officer 1607 PONCE DE LEON AVENUE, SUITE 407, SAN JUAN PR 00909
Stephen M Peck director P O BOX 554, 3600 S LAKE DRIVE, ST FRANCIS WI, MILWAUKEE WI 53201-0554

Alseres Pharmaceuticals (Alseres Pharmaceuticals) Headlines